| Name | nalbuphine hydrochloride |
|---|---|
| Synonyms |
Nalbuphine hydrochloride
17-(Cyclobutylmethyl)-4,5-epoxymorphinan-3,6,14-triol hydrochloride hydrate 17-(Cyclobutylmethyl)-4,5-epoxymorphinan-3,6,14-triol Nalbuphine hydrochloride hydrate (4R,4aS,7S,7aR,12bS)-3-(cyclobutylmethyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol,hydrochloride |
| Boiling Point | 566.6ºC at 760 mmHg |
|---|---|
| Melting Point | 230.5ºC |
| Molecular Formula | C21H28ClNO4 |
| Molecular Weight | 393.90400 |
| Flash Point | 296.5ºC |
| Exact Mass | 393.17100 |
| PSA | 73.16000 |
| LogP | 2.44720 |
| Vapour Pressure | 1.12E-13mmHg at 25°C |
| Storage condition | ?20°C |
| Water Solubility | H2O: soluble |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS02, GHS06, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H225-H301 + H311-H330-H370 |
| Precautionary Statements | P210-P260-P280-P284-P301 + P310-P310 |
| Hazard Codes | T+: Very toxic; |
| Risk Phrases | 26/27/28 |
| Safety Phrases | 22-36/37/39-45 |
| RIDADR | UN 1544 |
| RTECS | QD3181000 |
| Packaging Group | II |
| Hazard Class | 6.1(a) |
|
~86%
23277-43-2 |
| Literature: JOHNSON MATTHEY PUBLIC LIMITED COMPANY; WILSON, George Scott; YOUNG, Maureen Joan Patent: WO2011/21029 A1, 2011 ; Location in patent: Page/Page column 4 ; |
|
~%
23277-43-2 |
| Literature: WO2011/21029 A1, ; |
| Precursor 2 | |
|---|---|
| DownStream 0 | |